Categories Annual ReportsCorporate GovernanceDefault CalendarFeatured DocumentsPresentationsProxy Statements Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Title Supernus Announces Issuance of Third US Patent Protecting Trokendi XR™ Supernus Announces Fourth Quarter and Full Year 2013 Results Supernus to Host Fourth Quarter and Full Year 2013 Earnings Conference Call Supernus to Present at Cowen and Company Healthcare Conference in March Supernus at Citibank and RBC Global Healthcare Conferences in February Supernus Announces Publication of Phase III Study (PROSPER) Results on Oxtellar XR® Supernus Announces Issuance of First Use Patents Protecting SPN-812 as a Novel Non-Stimulant ADHD Product Supernus Announces Issuance of Third US Patent Protecting Oxtellar XR(R) Supernus Announces Resignation of Board Member Supernus Announces FDA Approval of Its Partner's Product, Orenitram(TM) Pagination First page « first Previous page ‹ previous … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page next › Last page last »